Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie's Hopes of Replacing Humira Sales with Rinvoq Gains Momentum for Ulcerative Colitis
BioSpace
Wed, 12/9/20 - 11:21 pm
Tags:
AbbVie, Rinvoq, ulcerative colitis, clinical trials
AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq
Endpoints
Wed, 12/9/20 - 10:39 am
Tags:
AbbVie, Allergan, Humira, Rinvoq
ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice
Fierce Pharma
Sun, 12/6/20 - 07:15 pm
Tags:
AstraZeneca, BeiGene, JNJ, AbbVie, Calquence, Brukinsa, Imbruvica, CLL, ASH2020
AbbVie pays Frontier $55M to pursue hard-to-drug targets
Fierce Biotech
Thu, 12/3/20 - 10:53 am
Tags:
AbbVie, Frontier Medicines, drug development
How AbbVie Beat Expectations in Q3
Motley Fool
Sun, 11/1/20 - 01:49 pm
Tags:
AbbVie, earnings, Humira
Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger
Endpoints
Wed, 10/28/20 - 10:50 am
Tags:
Allergan, AbbVie, presbyopia, clinical trials, AGN-190584
AbbVie’s Allergan Aesthetics brand gets a facelift
Fierce Pharma
Tue, 10/20/20 - 10:33 pm
Tags:
AbbVie, Allergan, aesthetics, branding
FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies
Pharmaforum
Mon, 10/19/20 - 10:56 am
Tags:
Roche, Genentech, AbbVie, Venclexta, AML, clinical trials, FDA
4 AbbVie brands land on pharma's top TV spenders list for September
Fierce Pharma
Sat, 10/17/20 - 11:46 pm
Tags:
television ads, DTC ads, AbbVie, Humira, Skyrizi, Rinvoq, Ubrelvy
Ironwood, AbbVie add 'bloating' and 'discomfort' to Linzess label to reach more IBS-C patients
Fierce Pharma
Fri, 10/9/20 - 10:55 am
Tags:
Ironwood, AbbVie, Linzess, IBS-C, FDA
Oxford University to test AbbVie's Humira as COVID-19 treatment
Beckers Hospital Review
Fri, 10/2/20 - 01:03 pm
Tags:
AbbVie, Humira, University of Oxford, clinical trials, COVID-19
Myovant shows disappointing prostate cancer data on the way to the FDA, stock sinks
Endpoints
Tue, 09/29/20 - 12:13 pm
Tags:
Myovant, Relugolix, prostate cancer, AbbVie, Lupron, clinical trials
FDA fast-tracks AbbVie’s spinal injury drug
Pharmaforum
Tue, 09/29/20 - 12:07 pm
Tags:
AbbVie, spinal injury, FDA, fast track, elezanumab
Bristol, Amgen, Teva CEOs among execs to testify at House drug pricing hearings next week
Fierce Pharma
Tue, 09/22/20 - 10:21 pm
Tags:
drug pricing, regulatory, Celgene, Bristol-Myers Squibb, Teva Pharmaceutical, Amgen, Novartis, Mallinckrodt, AbbVie, US Congress
Eli Lilly, squaring off against AbbVie and Biohaven, touts data showing early and lasting migraine relief from Reyvow
Fierce Pharma
Fri, 09/11/20 - 12:11 pm
Tags:
Eli Lilly, migraines, clinical trials, Reyvow, Biohaven, AbbVie
AbbVie has 47 reasons for its $2B cancer immunotherapy partnership with I-Mab
MedCity News
Sun, 09/6/20 - 07:19 pm
Tags:
AbbVie, I-Mab Biopharma, Forty Seven, lemzoparlimab, cancer immunotherapy
AbbVie puts $2B on the table for I-Mab cancer collab as biotech nabs $418M raise
Fierce Biotech
Fri, 09/4/20 - 02:43 pm
Tags:
AbbVie, I-Mab Biopharma, R&D, biobucks
UroGen presses ahead with RTGel after Botox pairing stumbles in overactive bladder trial
Fierce Pharma
Thu, 09/3/20 - 11:52 pm
Tags:
Urogen, AbbVie, Jelmyto, overactive bladder
AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman
Fierce Pharma
Tue, 09/1/20 - 12:28 pm
Tags:
AbbVie, Imbruvica, Humira, drug pricing, patents
AbbVie & UroGen Overactive Bladder Treatment Misses in Phase 2 Trial
Xconomy
Thu, 08/27/20 - 10:22 pm
Tags:
AbbVie, Urogen, overactive bladder, Allergan, Botox

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.